- Home
- CETY vs BCDA Comparison
CETY vs BCDA Comparison
Compare CETY & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CETY
- BCDA
- Stock Information
- Founded
- CETY 1993
- BCDA N/A
- Country
- CETY United States
- BCDA United States
- Employees
- CETY N/A
- BCDA N/A
- Industry
- CETY Power Generation
- BCDA Biotechnology: Pharmaceutical Preparations
- Sector
- CETY Utilities
- BCDA Health Care
- Exchange
- CETY Nasdaq
- BCDA Nasdaq
- Market Cap
- CETY 12.2M
- BCDA 11.3M
- IPO Year
- CETY N/A
- BCDA N/A
- Fundamental
- Price
- CETY $2.40
- BCDA $1.49
- Analyst Decision
- CETY
- BCDA Strong Buy
- Analyst Count
- CETY 0
- BCDA 1
- Target Price
- CETY N/A
- BCDA $25.00
- AVG Volume (30 Days)
- CETY 240.5K
- BCDA 374.2K
- Earning Date
- CETY 11-18-2025
- BCDA 11-12-2025
- Dividend Yield
- CETY N/A
- BCDA N/A
- EPS Growth
- CETY N/A
- BCDA N/A
- EPS
- CETY N/A
- BCDA N/A
- Revenue
- CETY $1,743,723.00
- BCDA N/A
- Revenue This Year
- CETY N/A
- BCDA N/A
- Revenue Next Year
- CETY N/A
- BCDA N/A
- P/E Ratio
- CETY N/A
- BCDA N/A
- Revenue Growth
- CETY N/A
- BCDA N/A
- 52 Week Low
- CETY $2.33
- BCDA $1.00
- 52 Week High
- CETY $19.05
- BCDA $3.20
- Technical
- Relative Strength Index (RSI)
- CETY 71.07
- BCDA 48.23
- Support Level
- CETY $2.56
- BCDA $1.40
- Resistance Level
- CETY $3.05
- BCDA $1.42
- Average True Range (ATR)
- CETY 0.26
- BCDA 0.10
- MACD
- CETY 0.03
- BCDA 0.03
- Stochastic Oscillator
- CETY 79.08
- BCDA 67.86
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).